A Study in Adolescent and Adult Female Participants to Evaluate Clinical Symptom Improvement and the Safety of Gepotidacin During Treatment of Uncomplicated Urinary Tract Infections (Acute Cystitis)

Phase 3

GepotidacinA Study in Adolescent and Adult Female Participants to Evaluate Clinical Symptom Improvement and the Safety of Gepotidacin During Treatment of Uncomplicated Urinary Tract Infections (Acute Cystitis)

Sponsor:

GlaxoSmithKline

Code:

NCT06597344

Conditions

Urinary Tract Infections

Eligibility Criteria

Sex: Female

Age: 12+

Healthy Volunteers: Not accepted

Interventions

Gepotidacin

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-09. This information was provided to ClinicalTrials.gov by GlaxoSmithKline on 2025-03-25.